TEE
CALA

Tibra Equities Europe’s Calithera Biosciences, Inc CALA Stock Holding History

Tibra Equities Europe’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-7,925
Closed -$331K – 249
2021
Q2 		$331K Buy
+7,925
New +$348K 0.1% 114

Other funds holding CALA

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DMPV
Delphi Management Partners VIII San Mateo, California $138M AUM 56.74% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Tibra Equities Europe's CALA Position: Q3 2021 in Review

Tibra Equities Europe sold out of Calithera Biosciences, Inc (CALA) in Q3 2021, closing a stake of 7,925 shares — an estimated $331K sold.

Tibra Equities Europe first reported a position in CALA in Q2 2021 and held it in 1 quarter. The position peaked at $331K in Q2 2021. 66 funds tracked by Wall St. Rank hold CALA as of Q3 2021.

  • Tibra Equities Europe reported no remaining Calithera Biosciences, Inc position as of Q3 2021 after selling out during the quarter.
  • Tibra Equities Europe sold 7,925 Calithera Biosciences, Inc shares in Q3 2021, an estimated $331K.
  • Tibra Equities Europe first reported a position in Calithera Biosciences, Inc in Q2 2021 and held it in 1 quarter.
  • Tibra Equities Europe's Calithera Biosciences, Inc position peaked at $331K in Q2 2021.
  • 66 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q3 2021.

Based on Tibra Equities Europe's 13F filing for Q3 2021, filed 15 Nov 2021.